Rift Valley fever virus (RVFV) is an important human and animal pathogen in Africa and has been responsible for infections in travelers. Because of the aerosol infectivity and risk of dissemination of the virus, a need exists for simple, safe, serological tests for diagnosis. An enzyme-linked immunosorbent assay (ELISA) was developed to detect RVFV-specific immunoglobulin (immunoglobulin G [IgG] and IgM). In the test, a betapropiolactone-inactivated, sucrose-acetone-extracted, suckling mouse liver RVFV antigen was captured by mouse RVFV antibodies adsorbed to polystyrene plates. The test sample (human serum) was then added, and the binding of specific antibodies was indicated by alkaline phosphatase-conjugated swine anti-human IgG or IgM. A kt-capture IgM ELISA was also developed by using polystyrene plates coated with goat anti-human IgM incubated successively with serum sample, RVFV antigen, and indicator antibodies. The ELISA for RVFV-specific IgG proved to be more sensitive than hemagglutination inhibition or cQmplement fixation tests and almost as sensitive as the plaque reduction neutralization test in detecting specific antibodies in human sera after vaccination. The two ELISA IgM tests could detect specific IgM antibodies during the first 6 weeks after RVFV vaccination. Three injections of inactivated vaccine were given on days 0, 6 to 8, and 32 to 34. ELISA IgM values for sera obtained on days 6 to 8 were negative or in the lower range of significance, on days 32 to 34 they were strongly positive, and on days 42 to 52 they were waning. Later sera were negative. The plaque reduction neutralization test was negative on days 6 to 8 but rose progressively in later samples. These findings suggest that the three doses of RVFV vaccine induce a prolonged primary antibody response. The ELISA IgM could become an important tool for early diagnosis in açute human infection. A number of African sera, some of which were positive for RVFV by plaque reduction neutralization test, were also tested by ELISA IgG. There was good agreement between both tests.
Rift Valley fever (RVF) is an economically important arthropod-borne virus disease in Africa, primarily affecting sheep, goats, and cattle (13) . Until 1975, RVF was considered to be a benign febrile illness in humans; however, that year, fatal humap hemorrhagic fever and encephalitis were seen in association with RVF in South Africa (23) and Zimbabwe (20) . During RVF epidemics in Egypt in 1977 and 1978, a large number of human fatalities were reported (11) .
The clinical diagnosis of an RVF epizootic in an area in which the virus is known to occur may be relatively easy because most pregnant ewes and cows abort owing to the infection, and a high mortality is often seen among newborn lambs (13) . Human disease may occur simultaneously, particularly in exposed veterinarians and slaughterhouse workers. However, diagnosis is often delayed when RVF extends into new regions, and laboratory confirmation is necessary even in the presence of suspicious disease activity (17) .
Methods for measurement of antibodies to RVF virus (RVFV) have been developed. The hemagglutination inhibition (HI), complement fixation (CF), indirect immunofluorescence, and neutralization tests can be used to detect antibodies after the natural infection.
Effective RVF vaccines are available for both animal and human use (3, 7, 14) . It is important to measure the antibody response after immunization, and the plaque reduction neutralization test (PRNT) is often used since it is a specific (21) and sensitive test which is able to detect even low amounts * Corresponding author. of antibodies and since neutralizing antibodies are thought to correlate with protection (7) .
The enzyme-linked immunosorbent assay (ELISA) has been used for the detection of antibodies in other viral diseases and found to be a rapid, sensitive, and specific method (6, 8, 24) . The ELISA system was therefore applied for the detection of RVF antibodies of the immunoglobulin G (IgG) and IgM classes. This study evaluates the method for detection of RVF antibodies and compares results by ELISA, HI, CF, and PRNT tests with sera collected during an RVF vaccination program. Both ELISA systems (IgM and IgG) were also evaluated by using African sera collected during seroepidemiological surveys in Sierra Leone, the Central African Republic, and the Sinai.
MATERIALS AND METHODS
Virus strains. Zagazig Hospital (ZH) 501 strain of RVFV was originally isolated by James Meegan, NAMRU-3, Cairo, Egypt, from a fatal human case of hemorrhagic fever in Egypt in 1977, and it was used in the second fetal rhesus lung cell culture passage. The Entebbe strain of RVFV was isolated in Uganda from a mosquito in 1944 and passaged intraperitoneally 184 times in mice (14) .
Antigen. A betapropiolactone-inactivated, sucrose-acetone-extracted, mouse liver antigen was used for ELISA. The antigen had been manufactured by Government Services Division, Salk Institute, Swiftwater, Pa., for RVF HI serology, using the Entebbe strain of RVFV (22) . Vaccine (4) . Also, the sera of 57 Bedouins, living in the Sinai peninsula, were tested by PRNT, HI, and ELISA IgG.
Affinity chromatography. Affinity-purified antibodies were used to increase the sensitivity and decrease the background activity of the ELISA test (10) . The inactivated RVFV antigen was coupled to CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals, Uppsala, Sweden) by using 1 g of gel and 2 ml of undiluted hemagglutination antigen (2) . Rabbit or mouse ascites fluid (1 ml) was passed through the column. After 30 min of incubation at room temperature, the gel was washed with phosphate-buffered saline, and the adsorbed anti-RVF immunoglobulins were eluted from the column with 0.2 M glycine (pH 2.8). After elution, the pH was neutralized by Tris buffer, and the immunoglobulin were than dialyzed against phosphate-buffered saline overnight and concentrated 10 times in a Minicon concentrator. The final protein concentrations calculated from the optical density (OD) at 280 nm were 1.00 and 0.52 mg/ml for the rabbit and mouse antibodies, respectively.
ELISA procedures for detection of RVFV IgG antibodies. A double antibody (sandwich) ELISA was used to measure RVFV IgG antibodies. Affinity-purified mouse RVFV antibodies were diluted 1:160 in coating buffer (0.05 M sodium carbonate, pH 9.5 to 9.7) and added (100 iil) to 60 of the 96 wells (excluding the outer rows) of polystyrene microtiter plates (Cooke M 29 AR; Dynatech Laboratories). After 1 h of incubation at 37°C, the plates were washed in rinsing solution (saline with 0.05% Tween 20 and 100 U of penicillin and 100 ,ug of streptomycin per ml). After incubation at 37°C in a 5% CO2 atmosphere for 3 days, a second overlay was applied that was identical to the first but contained neutral red stain (1:9,000). Plaques were enumerated the next day. An 80% reduction of plaques was used as the index for virus neutralization titers. The lowest serum dilution tested was 1:10. All dilutions were performed in Hanks balanced salt solution buffered to pH 7.2 with 10 mM HEPES and containing 2% heated calf serum and 50 U of penicillin and 50 ,ug of streptomycin per ml.
CF and HI tests. Antigens for the tests were prepared from livers of RVFV-infected suckling mice by the sucroseacetone extraction method described by Clarke and Casals (5). The HI method was also performed as described by Clarke and Casals, using acetone extraction to remove nonspecific inhibitors (5 PRNT- positive African sera tested by ELISA IgG, all but one were positive by ELISA IgG. Sixty-four African sera negative by PRNT were also negative by ELISA IgG. There was a significant correlation (r = 0.74, P < 0.01) between PRNT titer and ELISA IgG OD reading (Fig. 2) for both groups.
A total of 57 sera from Bedouin living in the Sinai were tested by PRNT, HI, and ELISA IgG. All 57 were negative by PRNT, 28 (49%) had an HI titer of 1:10, and 22 (39%) had an HI titer of 1:20, a result considered as nonspecific inhibition of hemagglutination. All 57 were negative by ELISA IgG. Nine sera with positive titers to Sandfly fever Sicilian virus (PRNT titers of 1:10 to 1:160) were all negative by ELISA IgG.
ELISA for specific IgM compared with PRNT. A total of 76 sera from 21 individuals immunized with RVF vaccine were tested by PRNT and ELISA g-capture IgM technique. Sera from day 0 (n = 21) were all negative. Sera from days 6 to 8 (n = 23) were negative by PRNT and negative or weakly positive by ELISA IgM. Sera from days 32 to 34 (n = 19) and days 42 to 52 (n = 13) were positive by both PRNT and ELISA IgM. Figure 3 shows the development of RVFV antibodies by time as measured with ELISA p.-capture IgM, ELISA IgG, and PRNT. Sera collected at 6 months postvaccination (n = 15) and African sera (n = 26), all positive by PRNT, were negative by ELISA IgM.
Of 37 postvaccination sera, 6 were strongly positive, 10 were weakly or border-line positive, and 21 were negative by ELISA ,u-capture IgM; they were also tested by the indirect ELISA, using anti-human IgM conjugate. Both ELISA IgM (14) but has been satisfactory when stud laboratories (9, 22 ; C. J. Peters, J. M. Meegan Urbanski, unpublished data), although it is consi sensitive than PRNT (7, 14) . Our results col findings. The neutralization test, although se specific (16, 21) , requires cell culture or anim; Furthermore, work with live RVFV outside ende requires special containment laboratories (15) .
ELISA for RVFV IgG proved to be almost as PRNT when used on postvaccination sera. It sensitive than HI or CF, which failed to detect a most specimens positive in PRNT and ELISA were no false positive results in the ELISA IgG High-background activity due to nonspecific binding is a well-known problem in most ELISA systems. A high frequency of so-called "sticky sera" has been found during seroepidemiological studies in Africa. Sera collected in Sierra Leone and the Central African Republic gave a much higher OD reading in the control (test without antigen) compared with sera from Swedish soldiers. However, falsepositive readings due to nonspecific binding are minimized by subtracting the control OD reading from the test result. The greater variation in background activity in African sera is important to note since the usual procedure used (mean plus standard deviations) to estimate the cut-off between positive and negative results will cause it to increase considerably. Figure 3 
